APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclopentanone Oxime

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cyclopentanone Oxime Market Outlook and Growth Opportunities 2026

8 January 2026199 pages

Choose your research edition.

Industry ResearchCyclopentanone Oxime Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclopentanone Oxime Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Cyclopentanone Oxime Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclopentanone Oxime Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclopentanone Oxime Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cyclopentanone Oxime market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cyclopentanone Oxime is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyclopentanone Oxime is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclopentanone Oxime is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cyclopentanone Oxime market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cyclopentanone Oxime market include Liaoyang Hengye Chemical, Hubei Norna Technology and SimSon Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyclopentanone Oxime market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyclopentanone Oxime and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyclopentanone Oxime sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyclopentanone Oxime market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyclopentanone Oxime Segment by Company

Liaoyang Hengye Chemical

Hubei Norna Technology

SimSon Pharma

Cyclopentanone Oxime Segment by Type

Purity <99%

Purity ≥99%

Cyclopentanone Oxime Segment by Application

Pharmaceutical Intermediates

Agrochemical Intermediates

Fine Chemicals

Cyclopentanone Oxime Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cyclopentanone Oxime status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cyclopentanone Oxime market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cyclopentanone Oxime significant trends, drivers, influence factors in global and regions.

6. To analyze Cyclopentanone Oxime competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclopentanone Oxime market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclopentanone Oxime and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclopentanone Oxime.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyclopentanone Oxime market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cyclopentanone Oxime industry.

Chapter 3: Detailed analysis of Cyclopentanone Oxime manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cyclopentanone Oxime in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cyclopentanone Oxime in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cyclopentanone Oxime Industry Trends Table 2. Cyclopentanone Oxime Industry Drivers Table 3. Cyclopentanone Oxime Industry Opportunities and Challenges Table 4. Cyclopentanone Oxime Industry Restraints Table 5. Global Cyclopentanone Oxime Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cyclopentanone Oxime Revenue Share by Company (2021-2026) Table 7. Global Cyclopentanone Oxime Sales Volume by Company (t) & (2021-2026) Table 8. Global Cyclopentanone Oxime Sales Volume Share by Company (2021-2026) Table 9. Global Cyclopentanone Oxime Average Price (USD/kg) of Company (2021-2026) Table 10. Global Cyclopentanone Oxime Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cyclopentanone Oxime Key Company Manufacturing Base & Headquarters Table 12. Global Cyclopentanone Oxime Company, Product Type & Application Table 13. Global Cyclopentanone Oxime Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyclopentanone Oxime by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity <99% Table 18. Significant Companies of Purity ≥99% Table 19. Global Cyclopentanone Oxime Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Cyclopentanone Oxime Sales Volume by Type (2021-2026) & (t) Table 21. Global Cyclopentanone Oxime Sales Volume by Type (2027-2032) & (t) Table 22. Global Cyclopentanone Oxime Sales Volume Share by Type (2021-2026) Table 23. Global Cyclopentanone Oxime Sales Volume Share by Type (2027-2032) Table 24. Global Cyclopentanone Oxime Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cyclopentanone Oxime Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cyclopentanone Oxime Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cyclopentanone Oxime Sales Value Share by Type (2021-2026) Table 28. Global Cyclopentanone Oxime Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceutical Intermediates Table 30. Significant Companies of Agrochemical Intermediates Table 31. Significant Companies of Fine Chemicals Table 32. Global Cyclopentanone Oxime Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 33. Global Cyclopentanone Oxime Sales Volume by Application (2021-2026) & (t) Table 34. Global Cyclopentanone Oxime Sales Volume by Application (2027-2032) & (t) Table 35. Global Cyclopentanone Oxime Sales Volume Share by Application (2021-2026) Table 36. Global Cyclopentanone Oxime Sales Volume Share by Application (2027-2032) Table 37. Global Cyclopentanone Oxime Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Cyclopentanone Oxime Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Cyclopentanone Oxime Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Cyclopentanone Oxime Sales Value Share by Application (2021-2026) Table 41. Global Cyclopentanone Oxime Sales Value Share by Application (2027-2032) Table 42. Global Cyclopentanone Oxime Sales by Region: 2021 VS 2025 VS 2032 (t) Table 43. Global Cyclopentanone Oxime Sales by Region (2021-2026) & (t) Table 44. Global Cyclopentanone Oxime Sales Market Share by Region (2021-2026) Table 45. Global Cyclopentanone Oxime Sales by Region (2027-2032) & (t) Table 46. Global Cyclopentanone Oxime Sales Market Share by Region (2027-2032) Table 47. Global Cyclopentanone Oxime Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Cyclopentanone Oxime Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Cyclopentanone Oxime Sales Value Share by Region (2021-2026) Table 50. Global Cyclopentanone Oxime Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Cyclopentanone Oxime Sales Value Share by Region (2027-2032) Table 52. Global Cyclopentanone Oxime Market Average Price (USD/kg) by Region (2021-2026) Table 53. Global Cyclopentanone Oxime Market Average Price (USD/kg) by Region (2027-2032) Table 54. Global Cyclopentanone Oxime Sales by Country: 2021 VS 2025 VS 2032 (t) Table 55. Global Cyclopentanone Oxime Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Cyclopentanone Oxime Sales by Country (2021-2026) & (t) Table 57. Global Cyclopentanone Oxime Sales Market Share by Country (2021-2026) Table 58. Global Cyclopentanone Oxime Sales by Country (2027-2032) & (t) Table 59. Global Cyclopentanone Oxime Sales Market Share by Country (2027-2032) Table 60. Global Cyclopentanone Oxime Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Cyclopentanone Oxime Sales Value Market Share by Country (2021-2026) Table 62. Global Cyclopentanone Oxime Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Cyclopentanone Oxime Sales Value Market Share by Country (2027-2032) Table 64. Liaoyang Hengye Chemical Company Information Table 65. Liaoyang Hengye Chemical Business Overview Table 66. Liaoyang Hengye Chemical Cyclopentanone Oxime Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 67. Liaoyang Hengye Chemical Cyclopentanone Oxime Product Portfolio Table 68. Liaoyang Hengye Chemical Recent Development Table 69. Hubei Norna Technology Company Information Table 70. Hubei Norna Technology Business Overview Table 71. Hubei Norna Technology Cyclopentanone Oxime Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 72. Hubei Norna Technology Cyclopentanone Oxime Product Portfolio Table 73. Hubei Norna Technology Recent Development Table 74. SimSon Pharma Company Information Table 75. SimSon Pharma Business Overview Table 76. SimSon Pharma Cyclopentanone Oxime Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 77. SimSon Pharma Cyclopentanone Oxime Product Portfolio Table 78. SimSon Pharma Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Cyclopentanone Oxime Distributors List Table 82. Cyclopentanone Oxime Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Cyclopentanone Oxime Product Image Figure 2. Global Cyclopentanone Oxime Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclopentanone Oxime Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cyclopentanone Oxime Sales (2021-2032) & (t) Figure 5. Global Cyclopentanone Oxime Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Cyclopentanone Oxime Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity <99% Image Figure 10. Purity ≥99% Image Figure 11. Global Cyclopentanone Oxime Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Cyclopentanone Oxime Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cyclopentanone Oxime Sales Volume Share by Type (2021-2032) Figure 14. Global Cyclopentanone Oxime Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cyclopentanone Oxime Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cyclopentanone Oxime Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical Intermediates Image Figure 18. Agrochemical Intermediates Image Figure 19. Fine Chemicals Image Figure 20. Global Cyclopentanone Oxime Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 21. Global Cyclopentanone Oxime Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Cyclopentanone Oxime Sales Volume Share by Application (2021-2032) Figure 23. Global Cyclopentanone Oxime Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cyclopentanone Oxime Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Cyclopentanone Oxime Sales Value Share by Application (2021-2032) Figure 26. Global Cyclopentanone Oxime Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 27. Global Cyclopentanone Oxime Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Cyclopentanone Oxime Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Cyclopentanone Oxime Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Cyclopentanone Oxime Sales Value (2021-2032) & (US$ Million) Figure 31. North America Cyclopentanone Oxime Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Cyclopentanone Oxime Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Cyclopentanone Oxime Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Cyclopentanone Oxime Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cyclopentanone Oxime Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Cyclopentanone Oxime Sales Value (2021-2032) & (US$ Million) Figure 37. South America Cyclopentanone Oxime Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Cyclopentanone Oxime Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Cyclopentanone Oxime Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Cyclopentanone Oxime Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Cyclopentanone Oxime Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Cyclopentanone Oxime Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity <99%
  • Purity ≥99%
Applications
  • Pharmaceutical Intermediates
  • Agrochemical Intermediates
  • Fine Chemicals
Companies covered
  • Liaoyang Hengye Chemical
  • Hubei Norna Technology
  • SimSon Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclopentanone Oxime Sales Value (2021-2032)
  4. 1.2.2 Global Cyclopentanone Oxime Sales Volume (2021-2032)
  5. 1.2.3 Global Cyclopentanone Oxime Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cyclopentanone Oxime Market Dynamics
  1. 2.1 Cyclopentanone Oxime Industry Trends
  2. 2.2 Cyclopentanone Oxime Industry Drivers
  3. 2.3 Cyclopentanone Oxime Industry Opportunities and Challenges
  4. 2.4 Cyclopentanone Oxime Industry Restraints
3 Cyclopentanone Oxime Market by Company
  1. 3.1 Global Cyclopentanone Oxime Company Revenue Ranking in 2025
  2. 3.2 Global Cyclopentanone Oxime Revenue by Company (2021-2026)
  3. 3.3 Global Cyclopentanone Oxime Sales Volume by Company (2021-2026)
  4. 3.4 Global Cyclopentanone Oxime Average Price by Company (2021-2026)
  5. 3.5 Global Cyclopentanone Oxime Company Ranking (2024-2026)
  6. 3.6 Global Cyclopentanone Oxime Company Manufacturing Base and Headquarters
  7. 3.7 Global Cyclopentanone Oxime Company Product Type and Application
  8. 3.8 Global Cyclopentanone Oxime Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cyclopentanone Oxime Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cyclopentanone Oxime Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cyclopentanone Oxime Market by Type
  1. 4.1 Cyclopentanone Oxime Type Introduction
  2. 4.1.1 Purity <99%
  3. 4.1.2 Purity ≥99%
  4. 4.2 Global Cyclopentanone Oxime Sales Volume by Type
  5. 4.2.1 Global Cyclopentanone Oxime Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyclopentanone Oxime Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cyclopentanone Oxime Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cyclopentanone Oxime Sales Value by Type
  9. 4.3.1 Global Cyclopentanone Oxime Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyclopentanone Oxime Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cyclopentanone Oxime Sales Value Share by Type (2021-2032)
5 Cyclopentanone Oxime Market by Application
  1. 5.1 Cyclopentanone Oxime Application Introduction
  2. 5.1.1 Pharmaceutical Intermediates
  3. 5.1.2 Agrochemical Intermediates
  4. 5.1.3 Fine Chemicals
  5. 5.2 Global Cyclopentanone Oxime Sales Volume by Application
  6. 5.2.1 Global Cyclopentanone Oxime Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyclopentanone Oxime Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Cyclopentanone Oxime Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Cyclopentanone Oxime Sales Value by Application
  10. 5.3.1 Global Cyclopentanone Oxime Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyclopentanone Oxime Sales Value by Application (2021-2032)
  12. 5.3.3 Global Cyclopentanone Oxime Sales Value Share by Application (2021-2032)
6 Cyclopentanone Oxime Regional Sales and Value Analysis
  1. 6.1 Global Cyclopentanone Oxime Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyclopentanone Oxime Sales by Region (2021-2032)
  3. 6.2.1 Global Cyclopentanone Oxime Sales by Region: 2021-2026
  4. 6.2.2 Global Cyclopentanone Oxime Sales by Region (2027-2032)
  5. 6.3 Global Cyclopentanone Oxime Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cyclopentanone Oxime Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cyclopentanone Oxime Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cyclopentanone Oxime Sales Value by Region (2027-2032)
  9. 6.5 Global Cyclopentanone Oxime Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cyclopentanone Oxime Sales Value (2021-2032)
  12. 6.6.2 North America Cyclopentanone Oxime Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cyclopentanone Oxime Sales Value (2021-2032)
  15. 6.7.2 Europe Cyclopentanone Oxime Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cyclopentanone Oxime Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cyclopentanone Oxime Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cyclopentanone Oxime Sales Value (2021-2032)
  21. 6.9.2 South America Cyclopentanone Oxime Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cyclopentanone Oxime Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cyclopentanone Oxime Sales Value Share by Country, 2025 VS 2032
7 Cyclopentanone Oxime Country-level Sales and Value Analysis
  1. 7.1 Global Cyclopentanone Oxime Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cyclopentanone Oxime Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cyclopentanone Oxime Sales by Country (2021-2032)
  4. 7.3.1 Global Cyclopentanone Oxime Sales by Country (2021-2026)
  5. 7.3.2 Global Cyclopentanone Oxime Sales by Country (2027-2032)
  6. 7.4 Global Cyclopentanone Oxime Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cyclopentanone Oxime Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cyclopentanone Oxime Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cyclopentanone Oxime Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cyclopentanone Oxime Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cyclopentanone Oxime Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Liaoyang Hengye Chemical
  2. 8.1.1 Liaoyang Hengye Chemical Company Information
  3. 8.1.2 Liaoyang Hengye Chemical Business Overview
  4. 8.1.3 Liaoyang Hengye Chemical Cyclopentanone Oxime Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Liaoyang Hengye Chemical Cyclopentanone Oxime Product Portfolio
  6. 8.1.5 Liaoyang Hengye Chemical Recent Developments
  7. 8.2 Hubei Norna Technology
  8. 8.2.1 Hubei Norna Technology Company Information
  9. 8.2.2 Hubei Norna Technology Business Overview
  10. 8.2.3 Hubei Norna Technology Cyclopentanone Oxime Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hubei Norna Technology Cyclopentanone Oxime Product Portfolio
  12. 8.2.5 Hubei Norna Technology Recent Developments
  13. 8.3 SimSon Pharma
  14. 8.3.1 SimSon Pharma Company Information
  15. 8.3.2 SimSon Pharma Business Overview
  16. 8.3.3 SimSon Pharma Cyclopentanone Oxime Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SimSon Pharma Cyclopentanone Oxime Product Portfolio
  18. 8.3.5 SimSon Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyclopentanone Oxime Value Chain Analysis
  2. 9.1.1 Cyclopentanone Oxime Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyclopentanone Oxime Sales Mode & Process
  6. 9.2 Cyclopentanone Oxime Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyclopentanone Oxime Distributors
  9. 9.2.3 Cyclopentanone Oxime Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst